Cowen And Company »

Cellebrite Di Ltd Wt Exp 083026 shares owned by Cowen And Company

Quarter-by-quarter ownership of Cellebrite Di Ltd Wt Exp 083026 (CLBTW) shares owned by Cowen And Company from 13F filings

Historical chart of Cowen And Company investment in Cellebrite Di Ltd Wt Exp 083026

Tip: Access up to 7 years of quarterly data

All positions including Cellebrite Di Ltd Wt Exp 083026 held by Cowen And Company consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Cellebrite Di Ltd Wt Exp 083026 by Cowen And Company

Quarter filed Position value Share count Share price at filing
2023-12-31 $314k 200k 1.57
2023-09-30 $224k 176k 1.27

More positions owned by Cowen And Company

NVIDIA Corporation (NVDA)
Ptc Therapeutics I (PTCT)
Coinbase Global Com Cl A (COIN)
Avidity Biosciences Ord (RNA)
Sirius Xm Holdings (SIRI)
Tarsus Pharmaceuticals (TARS)
Churchill Capital Corp Vii Com Cl A (CVII)
Immunocore Hldgs Ads (IMCR)
Select Sector Spdr Tr Energy (XLE)
Rocket Pharmaceuticals (RCKT)
Mercer International (MERC)
Screaming Eagle Acquisitn Class A Ord Shs (SCRM)
Sage Therapeutics (SAGE)
Alibaba Group Hldg Sponsored Ads (BABA)
Imperial Oil Com New (IMO)

View all positions for Cowen And Company

Top funds holding Cellebrite Di Ltd Wt Exp 083026

LMR Partners
Greenhaven Road Investment Management
Highbridge Capital Management
Light Street Capital Management
Walleye Trading Advisors
Fort Baker Capital Management
Josh Arnold Investment Consultant
Privium Fund Management B.V.
Crescent Park Management
Millennium Management
Darlington Partners Capital Management
Jpmorgan Chase & Co
Marshall Wace
Cowen And Company
Cantor Fitzgerald, L. P.

View all funds holding Cellebrite Di Ltd Wt Exp 083026